Key points are not available for this paper at this time.
Estimates of individual patient risk, and epidemiologic studies assessing potential late effects, must use patient size–specific dose estimates—they cannot use only scanner output (volume CT dose index or dose-length product).
McCollough et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: